Searched for
BIOCON EARNINGS NEWS
West Bengal's electronics factory push; Fed jitters hit TCSWest Bengal is exploring ways to expand electronics manufacturing under EMC 2.0. This and more in today's ETtech Top 5.- Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equity benchmarks ended lower on Tuesday, snapping a three-session rally amid profit booking in financial, realty and consumer sto...
- Stocks in news: Paytm, Bajaj Auto, L&T, Bharti Airtel, Hero MotoCorpMarkets closed lower amid global headwinds and geopolitical worries. Several companies like Paytm, Bajaj Auto, and L&T are in focus due to ...
- Syngene shares zoom 17% even as firm’s Q4 net profit drops 19% YoY. What's driving the surge?Syngene shares surged despite a 19% YoY decline in Q4FY26 net profit to Rs 148 crore, as earnings rebounded sharply from Rs 15 crore in the...
- Biocon shares fall 3% after board approves fundraise of up to Rs 4,500 croreBiocon shares: The board approved a hike in the company’s authorised share capital from Rs 625 crore to Rs 700 crore, along with a correspo...
- Stocks in news: Tata Investment, Tata Power, L&T, Wipro, BioconThe company reported a net profit (before exceptional items) of Rs 1533 crore in the September 2024 quarter, compared with Rs 1,017 crore i...
- Stocks in news: Vodafone Idea, Biocon, PB Fintech, ZEEL, JSW SteelShares of ZEEL, JSW Steel, Godrej Industries, Glaxo and Sobha will be in focus as the companies will announce their quarterly results.
- Q4 results today: What's in store for Ashok Leyland, NMDC and BioconAshok Leyland's Q4 net sales are expected to increase by 35% YoY to Rs 11,786 crore, with net profit likely to decline 10% to Rs 807 crore....
- Biocon Q2 Results: Net profit drops 66% YoY to Rs 47 cr due to exceptional itemsTotal revenues rose 23% YoY for Q2FY23 at Rs 2,384 crore compared to Rs 1,945 crore in Q2FY22
- Biocon Q3 Results: Net profit rises 11% YoY to Rs 187 croreThe earnings before interest, tax depreciation and amortisation (EBITDA) rose 25% YoY to Rs 537 crore. The EBITDA margins for the third qua...
- Market Movers: NTPC, ICICI Bank, SBI, Motherson jump; 32 stocks ‘overbought'Banks were among the top drivers of the rally, with ICICI Bank rallying 5% and SBI 3.5%.
- Why Siddharth Sedani is betting on ITC & Deepak NitriteDeepak Nitrite profits were up by around 178%. EBITDA margins jumped to 23-24%.
- D-Street may be ignoring Biocon’s growth risksThe stock price has priced in all the near-term positives arising from the business — leaving little room for any risks.
- Biocon has potential for more upsides from current levels: Gaurang Shah"Biocon's product line up has been the result of investments of about Rs 250-300 crore that they had done about three years ago."
- Bullish on DB Corp, Biocon: Avinnash GorakssakarI would definitely put my bet on Biocon because clearly the management indicated that R&D expense was one of the key reasons lower margins,...
- Wait for another 4-5% dip to nibble into Asian Paints: Gaurang Shah"The company's numbers have been lower than expectations. The positivity, however, has been that global crude oil prices, which is their co...
- Expect market to remain range bound in near term: Gaurang Shah, Geojit BNP Paribas Financial Services'The earnings season and the talk by the FED to taper should possibly keep the market a little bit suppressed.'
- Market needs to look at Biocon as a bellwether stock: Kiran Mazumdar Shaw"The biggest problem is that investors do not want us to spend on R&D and R&D is a very integral part of our business."
- 'FDA denial on Flomax could turn a big dampner for Ranbaxy'Gaurang Shah, AVP, Geojit BNP Paribas to ET Now on Ranbaxy stocks.
- Religare upholds 'Buy' on Biocon at Rs 542Religare Research has maintained a ‘buy’ on Biocon post its second quarter earnings for the September quarter. It has set a target price of...
Load More
